Description
A protease inhibitor; inhibits trypsin (Ki = 1 nM), as well as various inflammatory proteases, including plasmin, kallikrein, and thrombin; inhibits entry of VSV particles pseudotyped with SARS-CoV or SARS-CoV-2 surface glycoprotein in Calu-3 cells and primary human lung epithelial cells at 50 µM; reduces the number of SARS-CoV-2 genomic equivalents, a marker of infection, in Calu-3 cells; inhibits sodium channel function in human airway epithelial cells (IC50 = 50 nM); enhances mucociliary clearance in sheep; dietary administration inhibits the production of TNF-α and chemokine (C-C motif) ligand 2 (CCL2) by monocytes, as well as proliferation of pancreatic stellate cells in a rat model of pancreatic fibrosis at 1 mg/kg
Formal name: 4-[[4-[(aminoiminomethyl)amino]benzoyl]oxy]-benzeneacetic acid, 2-(dimethylamino)-2-oxoethyl ester, monomethanesulfonate
Synonyms: Foipan|FOY 305
Molecular weight: 494.5
CAS: 59721-29-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Entry/fusion Inhibitors||Product Type|Biochemicals|Antivirals|Protease Inhibitors||Product Type|Biochemicals|Ion Channel Modulation|Blockers||Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Research Area|Cell Biology|Proteolysis|Cytosolic & Secreted Proteases||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Immunology & Inflammation|Pulmonary Diseases|COVID-19||Research Area|Infectious Disease|Viral Diseases|Coronaviruses